F-box and leucine-rich repeat protein 14 (FBXL14) belongs to the F-box protein family, crucial components in the ubiquitin-proteasome system responsible for protein degradation. Characterized by the F-box motif necessary for protein-protein interactions, FBXL14 also contains leucine-rich repeats (LRRs), which are typically implicated in protein-protein interactions, signaling, and cellular trafficking.
FBXL14 is part of the SCF (SKP1-cullin-F-box) E3 ubiquitin ligase complex. This complex tags proteins with ubiquitin, marking them for degradation by the proteasome. Through this mechanism, FBXL14 plays a role in regulating protein levels within the cell, thereby controlling various biological processes, including the cell cycle, signal transduction, and immune responses.
The precise biological functions of FBXL14 are not fully defined, but it is understood to contribute to the fine-tuning of cellular processes by targeting specific proteins for ubiquitination. This activity is essential for maintaining cellular homeostasis and responding to internal and external cues. Given its role in protein turnover, FBXL14 may be involved in pathological conditions where protein degradation is disrupted, such as cancer or neurodegenerative diseases.Understanding FBXL14's specific substrates and regulatory mechanisms is an area of ongoing research, which could provide further insights into the intricate network of protein homeostasis and reveal potential targets for diseases associated with protein misregulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could upregulate FBXL14 expression as a response to inhibited protein degradation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
An inhibitor of protein synthesis that might trigger compensatory mechanisms including the upregulation of FBXL14. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Another proteasome inhibitor, which could increase FBXL14 expression through feedback mechanisms. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A clinical proteasome inhibitor that could potentially enhance FBXL14 expression due to blocked proteolysis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that may increase gene transcription broadly, including that of FBXL14. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could upregulate genes by changing the methylation status of DNA, possibly affecting FBXL14. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A molecule that can regulate gene expression, possibly affecting proteins involved in the cell cycle like FBXL14. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Through its receptor, Vitamin D3 can modulate transcription and potentially influence FBXL14 expression. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As an inducer of oxidative stress, it may upregulate FBXL14 as part of the cellular stress response. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that could affect gene expression, potentially leading to increased levels of FBXL14. | ||||||